Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING)
Mauro Pettorruso, Roberto Guidotti, Giacomo d’Andrea, et al.
Psychiatry Research (2023) Vol. 327, pp. 115378-115378
Open Access | Times Cited: 22

Showing 22 citing articles:

The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data
Giacomo d’Andrea, Mauro Pettorruso, Giorgio Di Lorenzo, et al.
Journal of Affective Disorders (2023) Vol. 348, pp. 314-322
Closed Access | Times Cited: 23
TSF-MDD: A Deep Learning Approach for Electroencephalography-Based Diagnosis of Major Depressive Disorder with Temporal–Spatial–Frequency Feature Fusion
Wei Gan, R. P. Zhao, Yujie Ma, et al.
Bioengineering (2025) Vol. 12, Iss. 2, pp. 95-95
Open Access | Times Cited: 1
Anhedonia in bipolar depression treated with ketamine
Alina Wilkowska, Mariusz S. Wiglusz, Aleksandra Arciszewska, et al.
Bipolar Disorders (2024) Vol. 26, Iss. 4, pp. 356-363
Closed Access | Times Cited: 6
Use of ketamine for treatment resistant depression: updated review of literature and practical applications to a community ketamine program in Edmonton, Alberta, Canada
Carson Chrenek, Bryan Duong, Atul Khullar, et al.
Frontiers in Psychiatry (2024) Vol. 14
Open Access | Times Cited: 5
New trends in personalized treatment of depression
Gaia Sampogna, Claudia Toni, Pierluigi Catapano, et al.
Current Opinion in Psychiatry (2023) Vol. 37, Iss. 1, pp. 3-8
Closed Access | Times Cited: 15
Proximity-based solutions for optimizing autism spectrum disorder treatment: integrating clinical and process data for personalized care
Annarita Vignapiano, Francesco Monaco, Stefania Landi, et al.
Frontiers in Psychiatry (2025) Vol. 15
Open Access
Application of the Random Forest Algorithm for Accurate Bipolar Disorder Classification
Miguel Suárez, Ana M. Torres, P Blasco-Segura, et al.
Life (2025) Vol. 15, Iss. 3, pp. 394-394
Open Access
The Patient’s Perspective on the Effects of Intranasal Esketamine in Treatment-Resistant Depression
Maria Pepe, Giovanni Bartolucci, Ilaria Marcelli, et al.
Brain Sciences (2023) Vol. 13, Iss. 10, pp. 1494-1494
Open Access | Times Cited: 9
Dopaminergic dysfunction in the left putamen of patients with major depressive disorder
Antonio Maria D’Onofrio, Daniele Antonio Pizzuto, Rana Batir, et al.
Journal of Affective Disorders (2024) Vol. 357, pp. 107-115
Closed Access | Times Cited: 3
Intravenous (IV) ketamine versus intranasal esketamine for depression– Advantage IV ketamine?
Balwinder Singh, Simon Kung, Jennifer L. Vande Voort
Journal of Affective Disorders (2024) Vol. 356, pp. 564-567
Closed Access | Times Cited: 3
Predicting non-response to ketamine for depression: An exploratory symptom-level analysis of real-world data among military veterans
Eric A. Miller, Houtan Totonchi Afshar, Jyoti Mishra, et al.
Psychiatry Research (2024) Vol. 335, pp. 115858-115858
Open Access | Times Cited: 2
The association between ketamine and esketamine and suicidality: reports to the Food And Drug Administration Adverse Event Reporting System (FAERS)
Roger S. McIntyre, Rodrigo B. Mansur, Joshua D. Rosenblat, et al.
Expert Opinion on Drug Safety (2024), pp. 1-6
Closed Access | Times Cited: 2
Use of Esketamine Nasal Spray in Patients with Treatment‐Resistant Depression in Routine Practice: A Real‐World French Study
Ludovic Samalin, Lila Mékaoui, Maud Rothärmel, et al.
Depression and Anxiety (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 2
Heart Rate Variability as a Potential Predictor of Response to Intranasal Esketamine in Patients with Treatment-Resistant Depression: A Preliminary Report
Lorenzo Moccia, Giovanni Bartolucci, Maria Pepe, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4767-4767
Open Access | Times Cited: 2
Overcoming treatment-resistant depression with machine-learning based tools: a study protocol combining EEG and clinical data to personalize glutamatergic and brain stimulation interventions (SelecTool Project)
Mauro Pettorruso, Giorgio Di Lorenzo, Beatrice Benatti, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 1
Exploring vortioxetine combination with intranasal esketamine: A feasible alternative to SSRI/SNRI? - Insights from the REAL-ESK study
Giacomo d’Andrea, Andrea Miuli, Mauro Pettorruso, et al.
Journal of Affective Disorders (2024) Vol. 367, pp. 583-588
Closed Access | Times Cited: 1
Maintenance Repetitive Transcranial Magnetic Stimulation for Major Depressive Disorder
Salman Akram, Imaan Nanji, Ismail Deniz, et al.
Journal of Ect (2024)
Closed Access
Treatment Attrition, Concomitant Pharmaceutical Use, Temporal Claims-Based Utilization, and Real-World Characteristics Among Esketamine New Initiators in the United States, 2019-2022
Brandon G. Truax
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Electroconvulsive Therapy (ECT) in Major Depression: Oldies but Goodies
Je‐Yeon Yun, Yong‐Ku Kim
Advances in experimental medicine and biology (2024), pp. 187-196
Closed Access
Anhedonia is associated with a specific depression profile and poor antidepressant response
Antonina Luca, Maria Antonietta De Luca, Siegfried Kasper, et al.
The International Journal of Neuropsychopharmacology (2024) Vol. 27, Iss. 12
Open Access
Effects of Volatile Anaesthetics on Incidence of Postoperative Depression and Anxiety Symptoms in Elderly Patients: a Retrospective Analysis of a Prospective Cohort Study
Shaohua You, Xinyu Hao, Fuyang Cao, et al.
Journal of Psychiatric Research (2024) Vol. 181, pp. 179-187
Closed Access
Rebound effect, discontinuation, and withdrawal syndromes associated with drugs used in psychiatric and neurological disorders
Aleksandra Wisłowska-Stanek, Michał Jarkiewicz, Dagmara Mirowska‐Guzel
Pharmacological Reports (2024)
Closed Access
Page 1

Scroll to top